Simplify Logo

Full-Time

Senior Business Systems Analyst

Posted on 3/22/2024

Penumbra Inc

Penumbra Inc

1,001-5,000 employees

Develops medical devices for vascular conditions

Hardware
Biotechnology
Healthcare

Compensation Overview

$132.4k - $188.1kAnnually

Senior, Expert

Alameda, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • Bachelor’s degree in engineering, computer science, or related discipline
  • 12+ years related experience in medical device, pharmaceutical, or FDA-regulated industry
  • Advanced knowledge of Quality Engineering Principals and Regulatory Environment
  • Experience with regulated software installation, configuration, validation, and maintenance
  • Expert knowledge of GAMP guidelines, 21 CFR Part 11, and FDA requirements
  • Strong oral, written, and interpersonal communication skills
  • Strong leadership skills
  • Excellent organizational skills
  • Ability to prioritize assignments and handle multiple projects simultaneously
Responsibilities
  • Assure implementation, maintenance, and obsoletion of validated computerized systems in compliance
  • Assess performance of regulated systems
  • Lead, drive, and own projects related to Computerized Systems Validation initiatives
  • Work closely with management to support quality engineering initiatives
  • Create documentation to support design and development of solutions
  • Manage and execute the deviation process during testing
  • Work with end-users to gather, understand, and define business requirements
  • Provide quality support for design control and transfer activities
  • Facilitate internal development team’s quality reviews of requirements
  • Drive/assist in the development of business strategies

Penumbra Inc. specializes in creating medical devices aimed at treating neurovascular and peripheral vascular conditions. Their products, such as the Penumbra System and the Indigo System, are designed to assist healthcare professionals in addressing issues like stroke and other vascular diseases. These devices work by providing advanced tools for interventions in neurology and vascular surgery, allowing for effective treatment options. Unlike many competitors, Penumbra focuses on a specific range of conditions and invests heavily in research and development to continuously enhance their offerings. The company's goal is to deliver high-quality medical devices that meet the needs of healthcare providers and improve patient outcomes.

Company Stage

IPO

Total Funding

$3.4M

Headquarters

Alameda, California

Founded

2004

Growth & Insights
Headcount

6 month growth

4%

1 year growth

8%

2 year growth

17%
Simplify Jobs

Simplify's Take

What believers are saying

  • Penumbra's recent product launches, such as the BMX81 and BMX96 in Europe, demonstrate their commitment to expanding and improving their product portfolio.
  • Significant investments from firms like Jennison Associates LLC and Algert Global LLC indicate strong financial backing and confidence in Penumbra's growth potential.
  • The company's participation in high-profile conferences like the Truist Securities MedTech Conference and the William Blair Growth Stock Conference highlights its industry recognition and thought leadership.

What critics are saying

  • The highly competitive medical device market requires Penumbra to continuously innovate to maintain its market position.
  • Regulatory challenges and the need for CE Marks and FDA approvals can delay product launches and impact revenue.

What makes Penumbra Inc unique

  • Penumbra's focus on both neurovascular and peripheral vascular conditions sets it apart from competitors who may specialize in only one area.
  • Their continuous investment in R&D ensures that they remain at the forefront of medical device innovation, particularly with recent launches like the Lightning Flash 2.0 CAVT technology.
  • Penumbra's global reach, serving healthcare providers in over 100 countries, provides a broad market presence that many competitors lack.
INACTIVE